Portfolio company
Immunohelix
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Immunohelix develops immune cell-specific oligonucleotide delivery systems and therapeutics for pharmaceutical companies seeking targeted treatments for immunological diseases, infections, and cancers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
immunos
This biotechnology company develops immunomodulatory proteins and HLA-based biologic therapies for pharmaceutical companies and healthcare providers to treat cancer and autoimmune diseases.
immunique
This company develops immune therapeutics, including cell therapies and peptides, for patients with cancer and autoimmune diseases.
Immulus
The company develops manufacturing processes to selectively expand T-cells for drug development for pharmaceutical and biotechnology customers.
Nuntius Therapeutics
This company develops mRNA and gene-editing therapies using a programmable nanocarrier delivery platform for pharmaceutical companies and research institutions.
Iolyx Therapeutics
The company develops immunomodulatory medicines to treat ocular inflammation and autoimmune eye diseases for patients worldwide.
Chameleon Biosciences
This company develops immune-evading gene therapy delivery platforms for pharmaceutical firms and patients with genetic disorders.
Exomnis Biotech
This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
